Pers YM - Search Results

1

Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice.

Pers YM, Fortunet C, Constant E, Lambert J, Godfrin-Valnet M, De Jong A, Mercier G, Pallot Prades B, Wendling D, Gaudin P, Jorgensen C, Marotte H, Maillefert JF. Pers YM, et al. Rheumatology (Oxford). 2014 Jan;53(1):76-84. doi: 10.1093/rheumatology/ket301. Epub 2013 Sep 19. Rheumatology (Oxford). 2014. PMID: 24056521

2

Unusual seminoma revealed by bone metastasis.

Braquet P, Chapelle A, Jorgensen C, Pers YM. Braquet P, et al. Among authors: pers ym. Joint Bone Spine. 2011 Dec;78(6):644-5. doi: 10.1016/j.jbspin.2011.05.012. Epub 2011 Jul 2. Joint Bone Spine. 2011. PMID: 21724441

3

Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: two case reports and review of literature.

Spoerl D, Pers YM, Jorgensen C. Spoerl D, et al. Among authors: pers ym. Allergy Asthma Clin Immunol. 2012 Dec 19;8(1):19. doi: 10.1186/1710-1492-8-19. Allergy Asthma Clin Immunol. 2012. PMID: 23253567 Free PMC article.

4

MicroRNA in 2012: Biotherapeutic potential of microRNAs in rheumatic diseases.

Pers YM, Jorgensen C. Pers YM, et al. Nat Rev Rheumatol. 2013 Feb;9(2):76-8. doi: 10.1038/nrrheum.2012.236. Epub 2013 Jan 15. Nat Rev Rheumatol. 2013. PMID: 23321608 Review.

5

Acute inflammatory myalgia: think of myositis ossificans circumscripta.

Galeano A, Fraison JB, Viala P, Le Blay P, Jorgensen C, Pers YM. Galeano A, et al. Among authors: pers ym. J Rheumatol. 2013 Sep;40(9):1614-5. doi: 10.3899/jrheum.130040. J Rheumatol. 2013. PMID: 23996994 No abstract available.

6

TNFRII polymorphism is associated with response to TNF blockers in rheumatoid arthritis patients seronegative for ACPA.

Pers YM, Cadart D, Rittore C, Ravel P, Daïen V, Fabre S, Jorgensen C, Touitou I. Pers YM, et al. Joint Bone Spine. 2014 Jul;81(4):370-2. doi: 10.1016/j.jbspin.2013.12.005. Epub 2014 Jan 22. Joint Bone Spine. 2014. PMID: 24462126 No abstract available.

7

Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.

Thiolat A, Semerano L, Pers YM, Biton J, Lemeiter D, Portales P, Quentin J, Jorgensen C, Decker P, Boissier MC, Louis-Plence P, Bessis N. Thiolat A, et al. Among authors: pers ym. Arthritis Rheumatol. 2014 Feb;66(2):273-83. doi: 10.1002/art.38246. Arthritis Rheumatol. 2014. PMID: 24504799

8

Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritis.

Duroux-Richard I, Pers YM, Fabre S, Ammari M, Baeten D, Cartron G, Touitou I, Jorgensen C, Apparailly F. Duroux-Richard I, et al. Among authors: pers ym. Mediators Inflamm. 2014;2014:342524. doi: 10.1155/2014/342524. Epub 2014 Mar 20. Mediators Inflamm. 2014. PMID: 24778468 Free PMC article.

9

Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis.

Pers YM, Schaub R, Constant E, Lambert J, Godfrin-Valnet M, Fortunet C, Bourichi W, Prades BP, Wendling D, Gaudin P, Jorgensen C, Maillefert JF, Marotte H. Pers YM, et al. Joint Bone Spine. 2015 Jan;82(1):25-30. doi: 10.1016/j.jbspin.2014.07.010. Epub 2014 Sep 17. Joint Bone Spine. 2015. PMID: 25241333

10

Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice.

Fortunet C, Pers YM, Lambert J, Godfrin-Valnet M, Constant E, Devilliers H, Gaudin P, Jorgensen C, Prades BP, Wendling D, Maillefert JF. Fortunet C, et al. Among authors: pers ym. Rheumatology (Oxford). 2015 Apr;54(4):672-7. doi: 10.1093/rheumatology/keu339. Epub 2014 Sep 22. Rheumatology (Oxford). 2015. PMID: 25246640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters